Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis. "We'll hopefully ...
Each separate part of a patient's health data is stored in separate ... reliable history for each piece of patient data. DeepMind's version will differ in parts to traditional blockchain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback